GTPases are involved with signaling of G protein-coupled receptor pathways and were previously implicated for CNVs associated with obesity [19]. ARFRP1 participates in the control of lipid droplet and chylomicron formation [29] and has been shown to affect glucose metabolism in the mouse [30]. This evidence concerns the gene ARFRP1 and obesity disorder.